Bartoletti R - Search Results

1

Epidemiological features and resistance pattern in uropathogens isolated from chronic bacterial prostatitis.

Cai T, Mazzoli S, Meacci F, Boddi V, Mondaini N, Malossini G, Bartoletti R. Cai T, et al. Among authors: bartoletti r. J Microbiol. 2011 Jun;49(3):448-54. doi: 10.1007/s12275-011-0391-z. Epub 2011 Jun 30. J Microbiol. 2011. PMID: 21717331

2

Urinary symptoms, quality of life and sexual function in patients with benign prostatic hypertrophy before and after prostatectomy: a prospective study.

Gacci M, Bartoletti R, Figlioli S, Sarti E, Eisner B, Boddi V, Rizzo M. Gacci M, et al. Among authors: bartoletti r. BJU Int. 2003 Feb;91(3):196-200. doi: 10.1046/j.1464-410x.2003.04072.x. BJU Int. 2003. PMID: 12581003

3

Nephrogenic adenoma of bladder after ibuprofen abuse.

Scelzi S, Giubilei G, Bartoletti R, Di Loro F, Mondaini N, Crisci A. Scelzi S, et al. Among authors: bartoletti r. Urology. 2004 Nov;64(5):1030. doi: 10.1016/j.urology.2004.06.050. Urology. 2004. PMID: 15533502

4

Early diagnosis and monitoring of superficial transitional cell carcinoma by microsatellite analysis on urine sediment.

Bartoletti R, Dal Canto M, Cai T, Piazzini M, Travaglini F, Gavazzi A, Rizzo M. Bartoletti R, et al. Oncol Rep. 2005 Mar;13(3):531-7. Oncol Rep. 2005. PMID: 15706429 Clinical Trial.

5

The Italian version of the National Institutes of Health Chronic Prostatitis Symptom Index.

Giubilei G, Mondaini N, Crisci A, Raugei A, Lombardi G, Travaglini F, Del Popolo G, Bartoletti R. Giubilei G, et al. Among authors: bartoletti r. Eur Urol. 2005 Jun;47(6):805-11. doi: 10.1016/j.eururo.2004.12.025. Epub 2005 Jan 14. Eur Urol. 2005. PMID: 15925077

6

Qualitative and quantitative analysis of angiogenetic factors in transitional cell bladder carcinoma: relationship with clinical course at 10 years follow-up.

Bartoletti R, Cai T, Nesi G, Sardi I, Rizzo M. Bartoletti R, et al. Oncol Rep. 2005 Jul;14(1):251-5. Oncol Rep. 2005. PMID: 15944797

7

Giant stone in enterocystoplasty.

Gacci M, Cai T, Travaglini F, Rizzo M, Bartoletti R, Carini M. Gacci M, et al. Among authors: bartoletti r. Urol Int. 2005;75(2):181-3. doi: 10.1159/000087175. Urol Int. 2005. PMID: 16123575 Review.

8

Intravesical gemcitabine therapy for superficial transitional cell carcinoma: results of a Phase II prospective multicenter study.

Bartoletti R, Cai T, Gacci M, Giubilei G, Viggiani F, Santelli G, Repetti F, Nerozzi S, Ghezzi P, Sisani M; TUR (Toscana Urologia) Group. Bartoletti R, et al. Urology. 2005 Oct;66(4):726-31. doi: 10.1016/j.urology.2005.04.062. Urology. 2005. PMID: 16230125 Clinical Trial.

9

Prognostic value of static cytometry in transitional cell carcinoma of the bladder: recurrence rate and survival in a group of patients at 10 years follow-up.

Cai T, Margallo E, Nesi G, Giubilei G, Rizzo M, Bartoletti R. Cai T, et al. Among authors: bartoletti r. Oncol Rep. 2006 Jan;15(1):213-9. Oncol Rep. 2006. PMID: 16328058

10

Intravesical gemcitabine in BCG-refractory T1G3 transitional cell carcinoma of the bladder: a pilot study.

Gacci M, Bartoletti R, Cai T, Nerozzi S, Pinzi N, Repetti F, Viggiani F, Ghezzi P, Nesi G, Carini M; TUR (Toscana Urologia) Group. Gacci M, et al. Among authors: bartoletti r. Urol Int. 2006;76(2):106-11. doi: 10.1159/000090870. Urol Int. 2006. PMID: 16493208 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

273 results

Search Page

Filters